Philanthotoxin-343 attenuates retinal and optic nerve injury, and protects visual function in rats with N-methyl-D-aspartate-induced excitotoxicity by Abu, Izuddin Fahmy
RESEARCH ARTICLE
Philanthotoxin-343 attenuates retinal and
optic nerve injury, and protects visual function
in rats with N-methyl-D-aspartate-induced
excitotoxicity
Muhammad Fattah Fazel1, Izuddin Fahmy AbuID
1*, Mohamad Haiqal Nizar Mohamad1,
Renu Agarwal2, Igor Iezhitsa2, Nor Salmah Bakar3, Norsham JulianaID
4, Ian R. Mellor5,
Henrik Franzyk6
1 Institute of Medical Science Technology, Universiti Kuala Lumpur, Kuala Lumpur, Malaysia, 2 School of
Medicine, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia, 3 Faculty of Medicine,
Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia, 4 Faculty of Medicine & Health Sciences,
Universiti Sains Islam Malaysia, Indah, Kuala Lumpur, Malaysia, 5 School of Life Sciences, Faculty of
Medicine & Health Sciences, University of Nottingham, Nottingham, United Kingdom, 6 Department of Drug




Retinal ganglion cell (RGC) loss and optic neuropathy, both hallmarks of glaucoma, have
been shown to involve N-methyl-D-aspartate receptor (NMDAR)-mediated excitotoxicity.
This study investigated the neuroprotective effects of Philanthotoxin (PhTX)-343 in NMDA-
induced retinal injury to alleviate ensuing visual impairments. Sprague-Dawley rats were
divided into three; Group I was intravitreally injected with phosphate buffer saline as the con-
trol, Group II was injected with NMDA (160 nM) to induce retinal excitotoxic injury, while
Group III was injected with PhTX-343 (160 nM) 24 h prior to excitotoxicity induction with
NMDA. Rats were subjected to visual behaviour tests seven days post-treatment and sub-
sequently euthanized. Rat retinas and optic nerves were subjected to H&E and toluidine
blue staining, respectively. Histological assessments showed that NMDA exposure resulted
in significant loss of retinal cell nuclei and thinning of ganglion cell layer (GCL). PhTX-343
pre-treatment prevented NMDA-induced changes where the RGC layer morphology is simi-
lar to the control. The numbers of nuclei in the NMDA group were markedly lower compared
to the control (p<0.05). PhTX-343 group had significantly higher numbers of nuclei within
100 μm length and 100 μm2 area of GCL (2.9- and 1.7-fold, respectively) compared to
NMDA group (p<0.05). PhTX-343 group also displayed lesser optic nerve fibres degenera-
tion compared to NMDA group which showed vacuolation in all sections. In the visual behav-
iour test, the NMDA group recorded higher total distance travelled, and lower total immobile
time and episodes compared to the control and PhTX-343 groups (p<0.05). Object recogni-
tion tests showed that the rats in PhTX-343 group could recognize objects better, whereas
the same objects were identified as novel by NMDA rats despite multiple exposures
(p<0.05). Visual performances in the PhTX-343 group were all comparable with the control
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(p>0.05). These findings suggested that PhTX-343 inhibit retinal cell loss, optic nerve dam-
age, and visual impairments in NMDA-induced rats.
Introduction
Glaucoma is one of the leading cause of irreversible blindness globally [1–4]. It could be cate-
gorized into primary open angle, normal tension, angle closure, and congenital glaucoma [5].
The prevalence of glaucoma varies among people from different ethnicities and regions. Pri-
mary open angle glaucoma is more prevalent among people of African and European descent,
whereas primary angle closure glaucoma is more common in Asian countries especially
China. Normal tension, a subtype of primary open angle glaucoma, affects more people in East
Asia compared to Caucasians or individuals of African origin [1, 6]. Interestingly, it has been
reported that women are at higher risk of developing normal tension and acute angle closure
glaucoma compared to men [2]. In 2013, 64 million people suffered from the disease, and with
the aging world population, the number was postulated to increase to 80 million by 2020, and
112 million by 2040 [7, 8].
Primary open angle glaucoma has a multifactorial etiology, and the “cupping” of the optic
disc has been described as a distinguished clinical feature of the disease [9]. The progressive
optic nerve damage seen in this disease often leads to the patients’ loss of visual field which
ultimately lead to blindness [10].
Previous studies have demonstrated that the increased activity of N-methyl-D-aspartate
(NMDA) receptors appears to be implicated in the pathogenesis of glaucoma. NMDA recep-
tors are important in the synaptic transmission in the central nervous system where its NR2A
subunit has been shown to be abundantly distributed in the ganglion cell layer (GCL) of the
retina [11–13]. Overstimulation of NMDA receptors has been associated with increased intra-
cellular calcium ion concentration, which culminates into damage to retinal ganglion cells
(RGC) and their axons in the optic nerve [12, 14].
Currently available management therapies for glaucoma are directed towards the reduction
of intraocular pressure (IOP) [9]. Although elevated IOP is considered as the most important
risk factor in this disease, glaucomatous changes may occur despite normal IOP, and hence
many patients continue to develop RGC loss regardless of a reduction in IOP [9, 15, 16]. Thus,
new therapies that can protect against RGC apoptosis, while providing a simultaneous IOP
reduction, will be valuable for arresting the disease.
Previous studies using NMDA receptor antagonists have not shown significant protective
effects in human studies despite showing the benefits in animal model, and the reasons for
such contradictory results have been widely reviewed [17]. Accordingly, targeting NMDA
receptors is likely to yield beneficial outcomes, and these outcomes may in fact be dependent
on the type of drug-NMDA receptors interaction, which possibly allows its closure only to sup-
press excitotoxicity without interfering with physiological excitatory neurotransmission. In
this regard, philanthotoxin (PhTX) is a potential candidate. PhTX, a low-molecular-weight
toxin from wasps, has been shown to block both NMDA and nicotinic acetylcholine receptor
channels non-competitively [18–20]. PhTX-433 is the natural compound isolated from the
venom sac of the female wasp, Philanthus triangulum, mainly found in the Sahara Desert. The
compound, first discovered by T. Piek and colleagues, contains a butyryl/tyrosyl/polyamine
structure and exerts glutamate receptor-blocking properties including antagonism towards the
NMDA receptors [21–23]. Subsequently, its analogue, known as PhTX-343 (numerals denote
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the number of methylenes between the amino group of the spermine moiety from left to right)
was synthesized and shown to retain the pharmacological properties [18, 20, 24, 25]. The pres-
ent study aimed to assess the inhibitory effects of PhTX-343 against NMDA receptor-mediated
excitotoxicity resulting in neuroprotective effects in rat retinas.
Materials and methods
Animals
The study was carried out in accordance with The Association for Research in Vision and
Ophthalmology (ARVO) statement for use of animals for ophthalmic and vision research.
However, bilateral injections are made in this study to enable the evaluation of visual func-
tions. The study obtained ethical approval by the Animal Ethics Committee, Institute of Medi-
cal Science Technology, Universiti Kuala Lumpur (approval number: AEC/MESTECH-
UNIKL/2018/001), and The Committee on Animal Research and Ethics, Universiti Teknologi
MARA (approval number: UiTM CARE:239/2/2018(6/4/2018)). Male Sprague-Dawley rats
(200–250 g) were housed under standard animal house conditions, and 12 h light-dark cycle
with food and water available ad libitum. Pine shaving bedding were used and change three
times per week. Rats were acclimatized to laboratory conditions for one week and were sub-
jected to general systemic and ophthalmic examination. Those found normal were included in
the study while those with any ocular abnormalities were excluded.
Study design
The rats were randomly divided equally into three groups consisting of 12 rats each; Group I
was administered with phosphate buffer saline (PBS) which served as the control group,
Group II was injected with NMDA compound (Sigma-Aldrich) to induce excitotoxic retinal
injury, and Group III was treated with PhTX-343 (University of Copenhagen, Denmark) fol-
lowed by NMDA-induced retinal injury 24 h later.
All treatments were given bilaterally and intravitreally. Prior to injection, rats were anaes-
thetized via intraperitoneal injection of ketamine (80 mg/kg) and xylazine (12 mg/kg) mixture.
For the intravitreal injections, NMDA and PhTX-343 were diluted in 0.1 M of PBS to obtain a
final concentration of 160 nM. Injections were administered with a 26-gauge 10 μl Hamilton
syringe. The total injection volume was 2 μl and administered with the aid of a dissecting
microscope. The intravitreal injections were made 1 mm from the superotemporal quadrant of
the dorsal limbus area performed slowly over 2 min to avoid any significant pressure-induced
retinal damages. Polymyxin and neomycin ointments were applied after injection to avoid
inflammation and infection [14, 26]. Post-intravitreal injection, none of rats were found to
develop any intraocular complications such as cataract or infection.
Seven days post-injection, the rats were subjected to visual behaviour assessments by using
an open field arena. To harvest the retinal and optic nerve tissues, rats were sacrificed by an
overdose of ketamine and xylazine mixture (>80 mg/kg and>12 mg/kg, respectively) in
accordance to animal ethical guidelines. Retinal tissues were subjected to hematoxylin and
eosin (H&E) staining to study the morphological changes by calculating the retinal cell density
per 100 μm2 or GCL area, and per 100 μm length of GCL. The optic nerves were isolated and
subjected to toluidine blue staining to assess the extent of optic nerve damage. The overall
study design is depicted in Fig 1.
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Assessment of retinal morphology by using H&E staining
The lenses were removed from the enucleated rat eyes and the retinas were isolated. The retinal
tissues were processed through a series of graded alcohol for at least 22 h, and then embedded
in paraffin wax. Retinal sections of 3 μm thickness were taken 1 mm from the temporal edge of
the optic disc. The sections were deparaffinized, stained with H&E according to standard pro-
tocol, and examined at 20× magnification under light microscopy. Three fields of view were
randomly chosen, and the images of the sections were saved (in jpeg format). Retinal morpho-
metric assessments were performed with Image J software (National Institutes of Health,
Bethesda, MD, USA). The parameters measured included the number of retinal cells in the
area (μm2) and length (μm) of GCL in the field of view. These measurements were used to cal-
culate the linear and numeric density of retinal cells in GCL [14, 26].
Assessment of optic nerve morphology by using toluidine blue staining
The optic nerves of rat eyes were cut 1 mm behind the eyeball and subjected to fixation over-
night in 10% formaldehyde. Subsequently, the tissues were processed through a series of
graded concentrations of alcohol and embedded in paraffin. Sections of 1 mm thickness were
cut, deparaffinized and subjected to staining with 1% toluidine blue according to standard pro-
tocol. Optic nerve morphology was assessed at 40× magnification under light microscopy. The
morphological changes in optic nerve were graded as previously described: Grade 1 = normal
optic nerve morphology; Grade 2 = moderate degeneration of axons in a focal area; Grade
3 = widespread degeneration of axons; Grade 4 = all axons showing degeneration [14, 26, 27].
Assessment of exploratory and locomotor activities of rats in open field test
The visual behaviour of rats after intravitreal injections was determined in an open field arena
that allows observation in relation to stress and anxiety-related changes in exploratory and
locomotor activities. Rats were expected to exhibit stress and anxiety-related behaviour in
open field if their vision were altered. This method was conducted according to a previously
validated protocol [28, 29]. The open field arena consisted of a PVC square apparatus (100 cm
[L] × 70 cm [H] × 100 cm [W]), and the experiment was conducted in a soundproof room. A
camera was installed above the arena for recording of animal activities. Each rat was placed in
Fig 1. Study design.
https://doi.org/10.1371/journal.pone.0236450.g001
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the centre of the square, and was let free to explore the arena for 10 min (trial 1). This was fol-
lowed by object recognition training and testing phase with object displacement and replace-
ment (further described below). The total distance travelled, total immobile time and total
immobile episodes for each rat were recorded. To prevent transmission of olfactory cues, the
arena was swabbed with 75% ethanol solution between trials. All parameters were analyzed
and recorded using ANY-maze software (Stoelting Co., USA) [28–31].
Object recognition test using open field arena
The experiment comprised of two parts, training phase (trials 2–4) and testing phase (trials
5–7), which involve object displacement and replacement. Six objects were used in this study:
(A) glass cylindrical water bottle with a rounded end ( ), (B) hexagon-shaped bottle ( ),
(C) cone-shaped bottle ( ), (D) cube-shaped bottle ( ), (E) jam jar ( ), and (A1)
sphere jar ( ). After trial 1 (10 min of habituation time in the open field arena), objects
(A-E) were placed in the arena and the rats were then allowed to explore around the five
objects (trial 2–4). This phase is also called the familiarization phase. Then, in the subsequent
trials 5 and 6 (object displacement test), object D ( ) was removed and replaced with object
E ( ), then object D ( ) was positioned between objects A ( ) and B ( ). This is fol-
lowed with trial 7 (object replacement test) where object A ( ) was replaced with a novel
object A1 ( ). Trials 2–7 were conducted for 5 min each. The movements and feedback
from the rats were recorded and analyzed by using the ANY-maze software. The arena was
swabbed with 75% ethanol solution before each trial to prevent transmission of olfactory cues
[28, 29]. Extra time spent at the novel object indicates their innate preference for novelty.
However, it was assumed that intravitreal injection of NMDA had no central effect and the
failure to recognize novel objects were mainly due to reduced vision. The experimental proce-
dure and the placement of objects is illustrated in Fig 2.
Statistical analysis
All data were expressed as mean ± standard error of the mean (SEM). After determination of
normality distribution by Shapiro-Wilk test, statistical significance for retinal morphological
analysis was assessed by using one-way analysis of variance (ANOVA) followed by post-hoc,
Tukey’s test for multiple comparisons performed on GraphPad Prism v8 (GraphPad Software.,
Fig 2. Design of object placements in the open field arena.
https://doi.org/10.1371/journal.pone.0236450.g002
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San Diego, CA). For optic nerve morphology and visual behaviour analysis, the data was non-
parametric, hence were statistically analyzed with Kruskal-Wallis test, followed by Dunn’s
multiple comparison test using SPSS 22.0 for Windows (SPSS Inc., Chicago, IL.). P values of
less than 0.05 were considered statistically significant for all analysis.
Results
Effects of PhTX-343 on retinal morphology
Retinal sections stained with H&E as displayed in Fig 3 showed a significant loss of retinal cell
nuclei and GCL thinning in Group II (NMDA-treated rats). The retinas of rats in the group
that received pre-treatment with PhTX-343 (Group III) displayed similar morphology to
Group I (control group administered with PBS). Quantitative retinal morphometric analysis
(the number of retinal cell nuclei counted within 100 μm2 area and along 100 μm length) was
performed to further assess the degree of retinal cell loss. The NMDA-treated rats showed a
significant low number of retinal cell nuclei/100 μm2 area of GCL as compared to that of con-
trol rats, corresponding to a 2.0-fold difference (p<0.05). In contrast, the cell density for the
PhTX-343 pre-treated rats (Group III) was 1.7-fold higher (p<0.05) than found for the
NMDA-treated Group II. The number of retinal cell nuclei/100 μm length in Group I and III
were also significantly higher (p<0.05) by 3.3 and 2.9 folds, respectively, as compared to that
found for the NMDA-treated Group II. Both parameters showed no significant differences
between Group I and III, indicating that PhTX-343 pre-treatment protected the rat retinas
from NMDA-induced injury.
Fig 3. Photomicrographs of retinal sections from each group stained with hematoxylin and eosin (H&E) seven
days after intravitreal injections. (A) PBS group presenting intact GCL, (B) NMDA group showing broad loss of
retinal cell nuclei, (C) PhTX-343 pre-treatment group followed by NMDA administration after 24 h showing minimal
loss of ganglion cells. The histological assessments were quantified with morphometric analysis and presented as a bar
graph: (D) number of retinal cell nuclei per 100 μm2 of GCL area, (E) number of retinal cell nuclei per 100 μm length
of GCL. Data were analyzed using one-way ANOVA followed by post-hoc Tukey’s multiple comparisons test: �p<0.05
versus PBS; #p<0.05 versus PhTX-343 (Scale bar 100 μm). GCL: ganglion cell layer, IPL: inner plexiform layer, IR:
inner retina layer.
https://doi.org/10.1371/journal.pone.0236450.g003
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Effects of PhTX-343 on optic nerve morphology
The observations on toluidine blue-stained optic nerve sections (Fig 4) were in accordance
with the retinal morphology. Normal optic nerve morphology was seen in Group I (control
group treated with PBS) showing packed, uniform axon fibres all over the sections. NMDA-
treated group showed extensive axonal degeneration all across the sections. Pre-treatment
with PhTX-343 prior to NMDA-induced injury resulted in lesser degeneration of axons with
only few vacuolations, and the morphology appeared similar to the control group. These
observations were supported by quantitative analysis of the optic nerve grading, demonstrating
that the NMDA-induced group had the most severe degenerative changes as compared to the
PBS group (p<0.05). PhTX-343 pre-treatment group exhibited less degenerative changes
when compared with the NMDA group (p<0.05) while showing similar morphology as the
control (p>0.05).
Effects of PhTX-343 on exploratory and locomotor activities
As shown in Fig 5, no difference was observed in the total distance travelled, immobile time
and immobile episodes from the three groups in the habituation phase (trial 1) of the open
field test, suggesting that the locomotor activity of rats were comparable across all groups.
However, when objects were introduced in the open field arena, the total distance travelled by
rats in the PhTX-343 group were significantly lower as opposed to the NMDA group
(p<0.05), but was comparable to the PBS group (p>0.05) across trials 2–7. Whereas for total
immobile time and immobile episodes, the numbers recorded by the PhTX-343 group were
Fig 4. Photomicrographs of optic nerve sections from each group stained with toluidine blue seven days after
intravitreal injections. (A) PBS group presenting intact optic nerve, (B) NMDA group showing extensive
degeneration and vacuolation of optic nerve, (C) PhTX-343 pre-treatment group followed by NMDA administration
after 24 h showing similar distribution of glial cells as in PBS group. The histological analysis was quantified by grading
the extent of injury for optic nerve degeneration across the three groups and presented as bar graph (D). ($) marks
degenerating fibres with vacuolation. The quantitative data were analyzed using Kruskal-Wallis with Dunn’s multiple
comparison test: �p<0.05 versus PBS; #p<0.05 versus PhTX-343 (Scale bar 50 μm).
https://doi.org/10.1371/journal.pone.0236450.g004
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significantly higher in contrast to the NMDA group (p<0.05) but comparable to the PBS
group (p>0.05) across trials 2–7, except for trial 2 and 3 with respect to total immobile time
and for trial 2 with regards to total immobile episode.
Effects of PhTX-343 on object recognition
The number of time spent around novel objects were similar in all groups during the object
familiarization stage of the object recognition test (Fig 6). When objects D ( ) and E ( )
were placed in different locations during the object displacement test, rats in the NMDA-
treated group exhibited a higher number of approaches at the non-displaced objects A ( ), B
( ), and C ( ) as compared to that seen for the newly repositioned objects. In contrast,
Fig 5. Effects of PhTX-343 on exploratory and locomotor activities using open field test in NMDA-induced rats.
(A) Total distance travelled, (B) total immobile time, and (C) total immobile episodes, recorded by the rats for each
group. Examples of track plots for each group are also displayed: (D) PBS, (E) NMDA, and (F) PhTX-343 groups
respectively. Statistical significance was conferred using Kruskal-Wallis test with Bonferroni correction: �p<0.05
versus PBS; #p<0.05 versus PhTX-343.
https://doi.org/10.1371/journal.pone.0236450.g005
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both PhTX-343 and PBS groups exhibited a higher number of approaches at objects D ( )
and E ( ) as opposed to the non-displaced objects. Comparison between groups showed
that NMDA-treated rats had a higher number of approaches at the non-displaced objects A
( ), B ( ), and C ( ) as compared to the PhTX-343 group by 2.1, 1.8 and 1.9 folds,
respectively (p<0.05). This lower activity of rats observed in the PhTX-343 group was compa-
rable to that seen in the PBS group (p>0.05).
In the object replacement stage, after object A ( ) was replaced with object A1 ( ),
PhTX-343-treated rats showed higher exploratory activities around the new object, resulting
in a significantly lower number of contacts at objects B ( ), C ( ), D ( ), and E ( )
as compared to that seen for the NMDA group, corresponding to 3.6, 2.3, 2.3 and 2.3 folds,
respectively (p<0.05). The number of approaches at all objects for PhTX-343 and PBS groups
were comparable with no statistically significant difference.
Discussion
Glaucoma is an ocular pathology that is characterized by the loss of RGC and optic nerve dam-
age leading to blindness [32]. Abnormally elevated IOP is also considered a characteristic of
glaucoma, however, lowering the IOP which is currently the standard practice of glaucoma
management does not necessarily prevent the progression of glaucoma. Numerous reports
Fig 6. Effects of PhTX-343 on object recognition using open field arena in NMDA-induced rats. The line charts display the number of approaches
by rats during: (A) familiarization phase, and examples of track plots for each group, (A1) PBS, (A2) NMDA, (A3) PhTX-343; (B) object displacement
test, and examples of track plots for each group, (B1) PBS, (B2) NMDA, (B3) PhTX-343; (C) object replacement test, and examples of track plots for
each group, (C1) PBS, (C2) NMDA, (C3) PhTX-343. Data were analyzed using Kruskal-Wallis test with Bonferroni correction: �p<0.05 versus PBS;
#p<0.05 versus PhTX-343.
https://doi.org/10.1371/journal.pone.0236450.g006
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have shown that despite IOP lowering, loss of visual field continues, and hence therapies that
may provide direct neuroprotection are of considerable interest [16].
From a therapeutic standpoint, the NMDA receptors are potential targets for treatment of
neurodegenerative diseases including prevention of RGC death and optic nerve damage in
glaucoma [33]. As proven by early in vitro models, the influx of calcium ions into the cyto-
plasm as a result of NMDA receptor overstimulation may initiate the apoptosis cascade [34].
As a consequence, neuronal cell death caused by the excitotoxic conditions will eventually lead
to many neurodegenerative disorders such as Alzheimer’s disease (AD), Huntington’s disease,
and stroke [34, 35]. Moreover, NMDA receptors are abundantly expressed in the retina, and
an in vivo model has shown that the administration of NMDA intravitreally leads to wide-
spread apoptosis of retinal cells due to excitotoxicity (causing high cellular influx of calcium
ions), which ultimately results in RGC death [32].
Currently, memantine is the only FDA-approved anti-AD drug, which targets the NMDA
receptor. However, this drug failed clinical trials as a potential intervention for glaucoma [36].
The present study, reveals for the first time that pre-treatment with PhTX-343 protects against
NMDA-induced retinal cell loss, optic nerve damage and visual impairment. The fact that
PhTX-343 directly blocks the NMDA receptor non-competitively especially with the presence
of a polyamine moiety, is presumably the reason why it exhibits neuroprotective effects [37,
38].
The present study demonstrates that pre-treatment with PhTX-343 prior to NMDA admin-
istration in rats results in reduced retinal cell loss as compared to the NMDA-treated group. In
addition, the retinal morphology in the PhTX-343-treated group was comparable to that seen
for the control group. In order to quantitatively assess the effect of PhTX-343 on retinal mor-
phology, we estimated the number of retinal cells in 100 μm2 area as well as 100 μm length of
GCL. This allowed more accurate assessment of retinal morphological changes. Cell counting
only in a specified volume may not display any changes if the volume is also reduced, which
appears a likely characteristic upon NMDA exposure. Conversely, cell counting during a speci-
fied length is expected to show changes despite the alteration in volume. Nevertheless, both the
linear as well as volumetric density of retinal cells in NMDA-treated rat eyes were significantly
lower than those observed in the control group, indicating significant retinal damage due to
NMDA exposure. On the other hand, the PhTX-343 pre-treatment group showed greater den-
sity of retinal cells in the GCL as compared to that of the NMDA group, indicating its protec-
tive effects against NMDA-induced retinal injury.
In accordance with the observations made on retinal morphology, pre-treatment with
PhTX-343 prior to NMDA exposure also resulted in lesser degenerative changes in the optic
nerve as compared to those found for NMDA-exposed eyes, and remained comparable to con-
trol eyes. On the contrary, exposure of rat eyes to NMDA without prior PhTX-343 treatment
resulted in extensive degeneration, which was characterized by swollen glial cells and clearing
of nerve fibres in the entire sections. The protective effects of PhTX-343 against NMDA-
induced retinal cell and optic nerve morphology observed in the present study may be attrib-
uted to its ability to counteract NMDA receptor activation in a non-competitive way, thereby
reducing calcium influx and subsequent apoptosis. In fact, PhTX-343 was earlier shown to
antagonize the increase in intracellular free calcium concentration in cerebellar granule cells
exposed to NMDA [34]. It was also shown to inhibit NMDA-induced currents across Xenopus
oocytes injected with rat brain RNA [39].
In order to assess the functional outcome of the changes in retinal and optic nerve mor-
phology, the exploratory activities of rats were studied in the open field test. Rats that were
exposed to NMDA, travelled a longer distance and were immobile for lesser time as compared
to the control group, indicating their discomfort and that they require longer exploration time
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to familiarize with the environment. Rats that were pre-treated with PhTX-343 exhibited sig-
nificantly longer periods of immobility as compared to the NMDA-treated rats indicating a
higher level of comfort. Previous studies have shown that rats that recognize the visual cues get
familiarized to the environment quickly, whereas those with poor vision require a longer time
to adapt [40, 41]. Hence, it is hypothesized that rats receiving pre-treatment with PhTX-343
retain normal vision and recognition of visual cues, thereby enabling readily familiarization
with the environment.
Subsequently, object recognition tests, involving displacement and replacement of objects,
were conducted similarly to the method proposed earlier by previous study [31]. In the object
displacement test, rats treated with either PhTX-343 or PBS were found to explore the newly
displaced objects more than the originally positioned objects, while the NMDA-treated rats
behaved totally divergent with a higher number of approaches at original objects in contrast to
relocated objects. This observation evidently infers that the rats in PhTX-343 and PBS groups,
which had learnt and visualized the shape and position of the objects from training during a
familiarization phase, preferentially explored the newly displaced objects at novel locations
rather than the original non-displaced objects [42]. This indicated that the PhTX-343 and PBS
groups possess a visual ability to explore better, while rats in the NMDA group were visually
impaired and only relied on their familiarized visualization of the original objects.
In the object replacement test, both PhTX-343 and PBS groups exhibited a higher number
of approaches at one novel object, which was newly introduced in the arena, as compared to
the other four original objects. The NMDA group, however, did not appear to show any differ-
ences between the number of approaches at all objects including the novel object. Akin to the
displacement test, this result indicate that the PhTX-343 and PBS groups managed to visualize
and learn the objects’ shape and their location in the arena, and hence were able to detect the
novel object being introduced, whereas the NMDA group did not recognize the new object as
being novel.
Our findings in both object displacement and replacement tests indicate the common trend
that NMDA-treated rats explored all objects with nearly equal frequency, whereas PhTX-343
pre-treated rats explored the novel objects with higher frequency as compared to the original
objects. Since the exploratory activities during the familiarization phase in open field test were
almost comparable among the three groups, all the rats were expected to display similar mem-
ory of the placement of objects. However, object displacement and replacement in the study
protocol made the visual cues more important than memory to recognize the familiar objects.
This observation provided evidence that rats in the NMDA group had difficulties in recogniz-
ing the objects indicating visual impairments, whereas the PhTX-343 group performed similar
to the control animals inferring preserved visual functions.
It is important to note that glaucoma is a multifactorial disorder. Besides NMDA receptor
overactivation, other mechanisms of ganglion cell apoptosis of axonal origin such as the loss of
retrograde transport of brain-derived neurotrophic factor (BDNF) from optic nerve projection
sites in the brain could also contribute to the pathogenesis of glaucoma [29] and the NMDA
receptor blockade alone may not be adequate enough for overall RGC protection. Neverthe-
less, this current study for the first time, provides evidence that PhTX-343 could be further
investigated for potential use against glaucomatous RGC loss.
Conclusion
Our data strongly suggest that PhTX-343 protects against NMDA-induced excitotoxic injuries
to rat retinas. This was evidenced by prevention of NMDA-induced changes in retinal and
optic nerve morphology, and by the vision-dependent behaviour of rats. Further studies are
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